vs
艾地盟（ADM）与MEDIFAST INC（MED）财务数据对比。点击上方公司名可切换其他公司
艾地盟的季度营收约是MEDIFAST INC的80.6倍（$6.1B vs $75.1M）。艾地盟同比增速更快（123.5% vs -36.9%）。MEDIFAST INC自由现金流更多（$-6.6M vs $-669.0M）。过去两年MEDIFAST INC的营收复合增速更高（-34.4% vs -47.4%）
艾地盟（ADM）是美国跨国食品加工与大宗商品贸易企业，1902年成立，总部位于伊利诺伊州芝加哥。集团在全球布局270多家加工厂及420多个农作物采购站点，将谷物、油籽加工为食品、饮料、营养保健、工业生产及动物饲料领域的各类产品，供应全球市场。
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业，该公司研发、分销并销售减重及健康相关产品，销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
ADM vs MED — 直观对比
营收规模更大
ADM
是对方的80.6倍
$75.1M
营收增速更快
ADM
高出160.4%
-36.9%
自由现金流更多
MED
多$662.4M
$-669.0M
两年增速更快
MED
近两年复合增速
-47.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $6.1B | $75.1M |
| 净利润 | $456.0M | — |
| 毛利率 | 20.0% | 69.4% |
| 营业利润率 | 7.9% | -10.4% |
| 净利率 | 7.5% | — |
| 营收同比 | 123.5% | -36.9% |
| 净利润同比 | -19.6% | — |
| 每股收益（稀释后） | $0.95 | $-1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMMED
| Q4 25 | $6.1B | $75.1M | ||
| Q3 25 | $6.4B | $89.4M | ||
| Q2 25 | $6.3B | $105.6M | ||
| Q1 25 | $6.1B | $115.7M | ||
| Q4 24 | $-25.7B | $119.0M | ||
| Q3 24 | $6.0B | $140.2M | ||
| Q2 24 | $22.2B | $168.6M | ||
| Q1 24 | $21.8B | $174.7M |
净利润ADMMED
| Q4 25 | $456.0M | — | ||
| Q3 25 | $108.0M | $-2.3M | ||
| Q2 25 | $219.0M | $2.5M | ||
| Q1 25 | $295.0M | $-772.0K | ||
| Q4 24 | $567.0M | — | ||
| Q3 24 | $18.0M | $1.1M | ||
| Q2 24 | $486.0M | $-8.2M | ||
| Q1 24 | $729.0M | $8.3M |
毛利率ADMMED
| Q4 25 | 20.0% | 69.4% | ||
| Q3 25 | 19.8% | 69.5% | ||
| Q2 25 | 21.6% | 72.6% | ||
| Q1 25 | 19.2% | 72.8% | ||
| Q4 24 | — | 74.1% | ||
| Q3 24 | 22.8% | 75.4% | ||
| Q2 24 | 6.3% | 73.2% | ||
| Q1 24 | 7.6% | 72.8% |
营业利润率ADMMED
| Q4 25 | 7.9% | -10.4% | ||
| Q3 25 | 2.3% | -4.6% | ||
| Q2 25 | 4.4% | -1.0% | ||
| Q1 25 | 5.7% | -1.1% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | 1.8% | 1.5% | ||
| Q2 24 | 2.7% | -4.7% | ||
| Q1 24 | 4.1% | 4.5% |
净利率ADMMED
| Q4 25 | 7.5% | — | ||
| Q3 25 | 1.7% | -2.5% | ||
| Q2 25 | 3.5% | 2.3% | ||
| Q1 25 | 4.8% | -0.7% | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 2.2% | -4.8% | ||
| Q1 24 | 3.3% | 4.8% |
每股收益（稀释后）ADMMED
| Q4 25 | $0.95 | $-1.64 | ||
| Q3 25 | $0.22 | $-0.21 | ||
| Q2 25 | $0.45 | $0.22 | ||
| Q1 25 | $0.61 | $-0.07 | ||
| Q4 24 | $1.21 | $0.08 | ||
| Q3 24 | $0.04 | $0.10 | ||
| Q2 24 | $0.98 | $-0.75 | ||
| Q1 24 | $1.42 | $0.76 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $167.3M |
| 总债务越低越好 | $7.6B | — |
| 股东权益账面价值 | $22.7B | $198.9M |
| 总资产 | $52.4B | $248.0M |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ADMMED
| Q4 25 | $1.0B | $167.3M | ||
| Q3 25 | $1.2B | $173.5M | ||
| Q2 25 | $1.1B | $162.7M | ||
| Q1 25 | $864.0M | $164.6M | ||
| Q4 24 | $611.0M | $162.3M | ||
| Q3 24 | $784.0M | $170.0M | ||
| Q2 24 | $764.0M | $163.5M | ||
| Q1 24 | $830.0M | $156.4M |
总债务ADMMED
| Q4 25 | $7.6B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.3B | — | ||
| Q3 24 | $7.6B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ADMMED
| Q4 25 | $22.7B | $198.9M | ||
| Q3 25 | $22.5B | $214.7M | ||
| Q2 25 | $22.4B | $216.0M | ||
| Q1 25 | $22.1B | $211.0M | ||
| Q4 24 | $22.2B | $210.1M | ||
| Q3 24 | $22.0B | $207.3M | ||
| Q2 24 | $22.2B | $205.3M | ||
| Q1 24 | $23.2B | $211.0M |
总资产ADMMED
| Q4 25 | $52.4B | $248.0M | ||
| Q3 25 | $51.9B | $268.2M | ||
| Q2 25 | $52.0B | $269.3M | ||
| Q1 25 | $53.4B | $280.0M | ||
| Q4 24 | $53.3B | $284.2M | ||
| Q3 24 | $52.2B | $291.2M | ||
| Q2 24 | $52.7B | $293.5M | ||
| Q1 24 | $54.8B | $302.8M |
负债/权益比ADMMED
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | 0.35× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-313.0M | $-5.3M |
| 自由现金流经营现金流 - 资本支出 | $-669.0M | $-6.6M |
| 自由现金流率自由现金流/营收 | -11.1% | -8.8% |
| 资本支出强度资本支出/营收 | 5.9% | 1.8% |
| 现金转化率经营现金流/净利润 | -0.69× | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | $1.2M |
8季度趋势，按日历期对齐
经营现金流ADMMED
| Q4 25 | $-313.0M | $-5.3M | ||
| Q3 25 | $1.8B | $12.1M | ||
| Q2 25 | $4.3B | $-3.4M | ||
| Q1 25 | $-342.0M | $3.4M | ||
| Q4 24 | $322.0M | $-4.9M | ||
| Q3 24 | $1.3B | $9.1M | ||
| Q2 24 | $468.0M | $13.1M | ||
| Q1 24 | $700.0M | $7.3M |
自由现金流ADMMED
| Q4 25 | $-669.0M | $-6.6M | ||
| Q3 25 | $1.5B | $10.8M | ||
| Q2 25 | $4.0B | $-4.8M | ||
| Q1 25 | $-633.0M | $1.9M | ||
| Q4 24 | $-170.0M | $-7.2M | ||
| Q3 24 | $919.0M | $7.7M | ||
| Q2 24 | $106.0M | $11.1M | ||
| Q1 24 | $372.0M | $5.4M |
自由现金流率ADMMED
| Q4 25 | -11.1% | -8.8% | ||
| Q3 25 | 23.6% | 12.0% | ||
| Q2 25 | 63.0% | -4.5% | ||
| Q1 25 | -10.3% | 1.6% | ||
| Q4 24 | 0.7% | -6.1% | ||
| Q3 24 | 15.3% | 5.5% | ||
| Q2 24 | 0.5% | 6.6% | ||
| Q1 24 | 1.7% | 3.1% |
资本支出强度ADMMED
| Q4 25 | 5.9% | 1.8% | ||
| Q3 25 | 4.6% | 1.5% | ||
| Q2 25 | 4.8% | 1.3% | ||
| Q1 25 | 4.7% | 1.3% | ||
| Q4 24 | -1.9% | 1.9% | ||
| Q3 24 | 6.4% | 1.0% | ||
| Q2 24 | 1.6% | 1.1% | ||
| Q1 24 | 1.5% | 1.1% |
现金转化率ADMMED
| Q4 25 | -0.69× | — | ||
| Q3 25 | 16.75× | — | ||
| Q2 25 | 19.63× | -1.36× | ||
| Q1 25 | -1.16× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 72.22× | 8.04× | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.96× | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADM
| Starchesandsweeteners | $1.4B | 23% |
| Ag Services | $1.1B | 18% |
| Human Nutrition | $961.0M | 16% |
| Refined Productsand Other | $924.0M | 15% |
| Animal Nutrition | $825.0M | 14% |
| Vantage Corn Processors | $700.0M | 12% |
| Transferred Over Time | $176.0M | 3% |
| Crushing | $59.0M | 1% |
MED
暂无分部数据
